Patient Size-Dependent Dosimetry Methodology Applied to ¹⁸F-FDG Using New ICRP Mesh Phantoms

Abstract

Despite the known influence of anatomic variability on internal dosimetry, dosimetry for 18 F-FDG and other diagnostic radiopharmaceuticals is routinely derived using reference phantoms, which embody population-averaged morphometry for a given age and sex. Moreover, phantom format affects dosimetry estimates to varying extent. Here, we applied newly developed mesh format reference phantoms and a patient-dependent phantom library to assess the impact of height, weight, and body contour variation on dosimetry of 18 F-FDG. We compared the mesh reference phantom dosimetry estimates with corresponding estimates from common software to identify differences related to phantom format or software implementation. Our study serves as an example of how more precise patient size-dependent dosimetry methodology could be performed.Methods: Absorbed dose coefficients were computed for the adult mesh reference phantoms and derivative patient-dependent phantom series by Monte Carlo simulation using the PHITS radiation transport code within PARaDIM software. The dose coefficients were compared with reference absorbed dose coefficients obtained from ICRP Publication 128, or generated using software including OLINDA 2.1, OLINDA 1.1, and IDAC-dose 2.1.Results: Differences in dosimetry arising from anatomical variations were shown to be significant, with detriment-weighted dose coefficients for the percentile-specific phantoms varying by up to ±40% relative to the corresponding reference phantom effective dose coefficients, irrespective of phantom format. Similar variations were seen in the individual organ absorbed dose coefficients for the percentile-specific phantoms relative to the reference phantoms. The effective dose coefficient for the mesh reference adult was 0.017 mSv/MBq, which was 5% higher than estimated by a corresponding voxel phantom, and 10% lower than estimated by the stylized phantom format. Conclusions:We observed notable variability in 18 F-FDG dosimetry across morphometrically different patients, supporting the use of patient-dependent phantoms for more accurate dosimetric estimations relative to standard reference dosimetry. These data may help in optimizing imaging protocols and research studies, in particular when longer-lived isotopes are employed. KEY POINTSQuestion: Can the influence of patient size on 18 F-FDG dosimetry be elucidated usingnewly-developed patient-dependent phantoms?Pertinent findings: Dose coefficients for 18 F-FDG were shown to vary by up to ± 40% across the 10 th -90 th percentiles for standing height and weight across the Caucasian adult patient population.Implications for patient care: Implementation of the current state-of-the-art phantom libraries into modernized dosimetry software will foster greater accuracy in dosimetry and ultimately support optimized strategies for personalized nuclear medicine.

Influence of Body Posture on Internal Organ Dosimetry: Radiocesium Exposure Modeling Using Novel Posture-dependent Mesh Computational Phantoms

“…Some radiosensitive targets defined by the ICRP have contributions from multiple volume regions. To compute absorbed dose coefficients for these regions, d ( r T , τ ) P , the mass-based dose-weighting scheme described in Carter et al (2021) was used. Tissue weighting factors defined in ICRP Publication 103 (ICRP 2007) were used to compute effective dose coefficients:…”

MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry

“…In comparing the similar dosimetry software packages, we can take note some differences. First, calculated absorbed doses to the urinary bladder were factors of 2-3 times higher in ICRP publication 128 than in MIRDcalc because of advances in the stylized dosimetry model used to compute absorbed fractions of energy deposited in the bladder wall from emissions in the urinary bladder contents (47,48). Next, MIRDcalc spheric tumor b-dosimetry was modeled using the entire b-energy spectrum, rather than the mean b-emission energy.…”

Sex-based differences in nuclear medicine imaging and therapy

“…Depending on a specific patient's BMI and international size percentile, one of nine size-specific male or female patients can be selected. Using these hybrid mesh phantoms, it was illustrated that the calculation of the effective dose of patients falling below the 10th or above the 90th percentile deviated 40% from the reference "average" patient [14] (within one sex category), clearly illustrating the high importance of personalized dose calculations.…”